Skip to main content
Erschienen in: Medicine, Health Care and Philosophy 3/2020

31.03.2020 | Scientific Contribution

Can reproductive genetic manipulation save lives?

verfasst von: G. Owen Schaefer

Erschienen in: Medicine, Health Care and Philosophy | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

It has recently been argued that reproductive genetic manipulation technologies like mitochondrial replacement and germline CRISPR modifications cannot be said to save anyone’s life because, counterfactually, no one would suffer more or die sooner absent the intervention. The present article argues that, on the contrary, reproductive genetic manipulations may be life-saving (and, from this, have therapeutic value) under an appropriate population health perspective. As such, popular reports of reproductive genetic manipulations potentially saving lives or preventing disease are not necessarily mistaken, though such terminology still requires further empirical validation.
Fußnoten
1
While this article will focus on the terminology of ‘saving lives’, the arguments are meant to apply mutatis mutandis to most benefit language pertaining to children born via rGMTs.
 
2
This would comport with focusing on rGMTs’ purported positive impact on societal welfare and overall morbidity/mortality rates. For an application of this more societal-level approach to benefit to MRT, see Wrigley et al. (2015).
 
3
This argument could also be run to show that preimplantation genetic screening, i.e., selecting only embryos for implantation that are free of significant genetic disorders, may be a life-saving intervention. But rGMTs are the focus of this paper because of the life-saving claims surrounding it that have been made; while this language is not used as much for genetic screening, by this argument it might be acceptable to use such language in that context as well.
 
Literatur
Zurück zum Zitat Craven, Lyndsey, Helen A. Tuppen, Gareth D. Greggains, Stephen J. Harbottle, Julie L. Murphy, Lynsey M. Cree, Alison P. Murdoch, et al. 2010. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465: 82–85. https://doi.org/10.1038/nature08958.CrossRef Craven, Lyndsey, Helen A. Tuppen, Gareth D. Greggains, Stephen J. Harbottle, Julie L. Murphy, Lynsey M. Cree, Alison P. Murdoch, et al. 2010. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465: 82–85. https://​doi.​org/​10.​1038/​nature08958.CrossRef
Zurück zum Zitat Elliot, Robert. 1993. Identity and the ethics of gene therapy. Bioethics 7: 27–40.CrossRef Elliot, Robert. 1993. Identity and the ethics of gene therapy. Bioethics 7: 27–40.CrossRef
Zurück zum Zitat Engelstad, Kristin, Miriam Sklerov, Joshua Kriger, Alexandra Sanford, Johnston Grier, Daniel Ash, Dieter Egli, et al. 2016. Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy. Human Reproduction 31: 1058–1065. https://doi.org/10.1093/humrep/dew033.CrossRef Engelstad, Kristin, Miriam Sklerov, Joshua Kriger, Alexandra Sanford, Johnston Grier, Daniel Ash, Dieter Egli, et al. 2016. Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy. Human Reproduction 31: 1058–1065. https://​doi.​org/​10.​1093/​humrep/​dew033.CrossRef
Zurück zum Zitat HFEA. 2014. Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 update. HFEA. 2014. Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 update.
Zurück zum Zitat Joseph, Rebecca. 2016. 3-parent babies: who’s eligible and what’s ethical? Global News, September 28. Joseph, Rebecca. 2016. 3-parent babies: who’s eligible and what’s ethical? Global News, September 28.
Zurück zum Zitat Nolte, Ellen, Martin McKee, David Evans, and Marina Karanikolos. 2012. Saving lives? The contribution of health care to population health. In Health systems, health, wealth and societal well-being: assessing the case for investing in health systems, ed. Josep Figueras and Martin McKee, 101–124. Berkshire and New York: Open University Press. Nolte, Ellen, Martin McKee, David Evans, and Marina Karanikolos. 2012. Saving lives? The contribution of health care to population health. In Health systems, health, wealth and societal well-being: assessing the case for investing in health systems, ed. Josep Figueras and Martin McKee, 101–124. Berkshire and New York: Open University Press.
Metadaten
Titel
Can reproductive genetic manipulation save lives?
verfasst von
G. Owen Schaefer
Publikationsdatum
31.03.2020
Verlag
Springer Netherlands
Erschienen in
Medicine, Health Care and Philosophy / Ausgabe 3/2020
Print ISSN: 1386-7423
Elektronische ISSN: 1572-8633
DOI
https://doi.org/10.1007/s11019-020-09947-2

Weitere Artikel der Ausgabe 3/2020

Medicine, Health Care and Philosophy 3/2020 Zur Ausgabe

Short Communication

Letter to the editor

Editorial

Suffering

Letter to editor

Letter to Editor